
Dexamethasone (0.1% w/v) + Moxifloxacin (0.5% w/v)
Active composition
+1 more active ingredient
Dexamethasone inhibits the release of pro-inflammatory cytokines and mediators, thereby reducing inflammation and immune response.
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Loxcip-DX Eye Drops is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial ocular infections accompanied by inflammation, such as bacterial conjunctivitis and keratitis. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and promoting eradication of susceptible pathogens. Dexamethasone provides anti-inflammatory action by suppressing the release of inflammatory mediators, reducing ocular redness, swelling, and discomfort. Loxcip-DX Eye Drops should be administered as directed by a healthcare professional, typically one to two drops instilled into the affected eye(s) every four to six hours. Caution is advised in patients with viral, fungal, or mycobacterial ocular infections, as corticosteroids may exacerbate these conditions. Prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary infections; therefore, treatment duration should be limited to the shortest effective period. Patients should avoid contact lens use during therapy and consult an ophthalmologist if symptoms persist or worsen. This product is contraindicated in individuals with hypersensitivity to any component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Loxcip-DX Eye Drops during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Loxcip-DX Eye Drops during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Loxcip-DX Eye Drops may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Loxcip-DX Eye Drops

Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Dexamethasone inhibits the release of pro-inflammatory cytokines and mediators, thereby reducing inflammation and immune response.
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Loxcip-DX Eye Drops is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone 0.1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial ocular infections accompanied by inflammation, such as bacterial conjunctivitis and keratitis. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and promoting eradication of susceptible pathogens. Dexamethasone provides anti-inflammatory action by suppressing the release of inflammatory mediators, reducing ocular redness, swelling, and discomfort. Loxcip-DX Eye Drops should be administered as directed by a healthcare professional, typically one to two drops instilled into the affected eye(s) every four to six hours. Caution is advised in patients with viral, fungal, or mycobacterial ocular infections, as corticosteroids may exacerbate these conditions. Prolonged use may increase the risk of elevated intraocular pressure, cataract formation, or secondary infections; therefore, treatment duration should be limited to the shortest effective period. Patients should avoid contact lens use during therapy and consult an ophthalmologist if symptoms persist or worsen. This product is contraindicated in individuals with hypersensitivity to any component.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Loxcip-DX Eye Drops during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Loxcip-DX Eye Drops during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Loxcip-DX Eye Drops may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Loxcip-DX Eye Drops















